Home : Privacy & Technology : Medical Privacy

ACLU Comments on National Institutes of Health Data Sharing (11/30/2006)

The ACLU's Chris Calabrese's Testimony Before the NCVHS (02/18/2004)

ACLU Letter to the House Judiciary Committee Expressing Concerns about HR 3214, the Advancing Justice through DNA Technology Act of 2003 (10/08/2003)

Letter to the House Regarding HR 4700, the Personal Responsibility, Work, and Family Promotion Act of 2002 (05/14/2002)

Submission of the American Civil Liberties Union in response to the request by the U.S. Department of Health and Human Services at 67 Fed. Reg. 14776 (March 27, 2002) for Comments Regarding Proposed Modifications to the Final Rule on Standards for Privacy of Individually Identifiable Health Information (04/26/2002)

Text of the MSEHPA (12/21/2001)

Letter to HHS Secretary Tommy Thompson Regarding TANF Program (11/30/2001)

Testimony of Legislative Consultant Ron Weich on the Implementation of Medical Privacy Regulations Before the National Committee on Vital and Health Statistics Subcommittee on Privacy and Confidentiality (08/22/2001)

Coalition Letter to Attorney General Ashcroft on Privacy Issues (05/02/2001)

Coalition Letter on HIPAA Medical Privacy Regulations (03/08/2001)

Memorandum on Medical Records Privacy (03/07/2001)

Letter to Reps. Scott and Barr on DNA Legislation - HR 4640 (08/31/2000)

Sign-on Letter to the House Urging Support for Amendments to Strengthen the Medical Privacy Act (06/28/2000)

Testimony of Legislative Consultant Ronald Weich on the Medical Financial Privacy Protection Act Before the House Committee on Banking and Financial Services (06/14/2000)

Testimony of Barry Steinhardt on CODIS before the House Judiciary Subcomitteee on Crime (03/23/2000)

Letter to the House on the Financial Services Act H.R. 10 (07/01/1999)

Testimony of Legislative Consultant Ronald Weich on Medical Records Confidentiality Before the Senate Committee on Health, Education, Labor, and Pensions (04/27/1999)

Comments on CDC Draft "Guidelines for National HIV Case Surveillance, Including Monitoring for HIV Infection and Acquired Immunodeficiency Syndrome (AIDS)" 63 Fed. Reg. 237, 68289 (01/11/1999)